Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$383,834,254
+$35,455,890 QoQ
Shares Held
2,987,037
+3.1% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#80
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. MRK ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
|
2,819,076 | $67,883,350 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $383,834,254 | 2,987,037 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $348,378,364 | 2,896,154 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $336,532,114 | 3,197,151 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $268,565,173 | 3,199,871 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $269,646,349 | 3,406,346 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $309,811,666 | 3,451,556 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $125,448,657 | 1,261,044 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $142,749,689 | 1,257,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $147,814,847 | 1,193,981 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $150,790,216 | 1,142,783 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $124,696,421 | 1,143,794 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $115,300,293 | 1,119,964 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $122,884,811 | 1,064,952 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $97,477,177 | 916,225 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $99,252,763 | 894,572 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $75,172,339 | 872,879 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $84,527,444 | 927,141 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $75,728,950 | 922,961 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $67,362,881 | 878,952 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $68,108,095 | 906,778 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $71,229,076 | 915,894 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $71,727,966 | 930,444 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $75,466,928 | 922,579 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $80,570,533 | 971,314 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $75,544,637 | 976,912 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $77,925,645 | 1,012,811 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||